Drug Type Synthetic peptide |
Synonyms |
Target |
Mechanism RXFP1 agonists(Relaxin receptor 1 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Fibrosis | Preclinical | US | 11 Aug 2023 | |
Heart Failure | Discovery | US | 01 Jan 2016 |